Ashleigh Williams
Anticancer effects of the Novel Pyrazolyl-Urea GeGe-3
Williams, Ashleigh; Cooper, Emma; Clark, Bethany; Perry, Laura; Ponassi, Marco; Iervasi, Erika; Brullo, Chiara; Greenhough, Alexander; Ladomery, Michael
Authors
Emma Cooper
Bethany Clark
Laura Perry
Marco Ponassi
Erika Iervasi
Chiara Brullo
Alexander Greenhough Alexander.Greenhough@uwe.ac.uk
Associate Professor of Health Diagnostics
Prof Michael Ladomery Michael.Ladomery@uwe.ac.uk
Professor of Genetics
Abstract
In a screen of over 200 novel pyrazole compounds, ethyl 1-(2-hydroxypentyl)-5-(3-(3-(trifluoromethyl) phenyl)ureido)-1H-pyrazole-4-carboxylate (named GeGe-3) has emerged as a potential anticancer compound. GeGe-3 displays potent anti-angiogenic properties through the presumptive targeting of the protein kinase DMPK1 and the Ca2+-binding protein calreticulin. We further explored the anticancer potential of GeGe-3 on a range of established cancer cell lines, including PC3 (prostate adenocarcinoma), SKMEL-28 (cutaneous melanoma), SKOV-3 (ovarian adenocarcinoma), Hep-G2 (hepatocellular carcinoma), MDA-MB231, SKBR3, MCF7 (breast adenocarcinoma), A549 (lung carcinoma), and HeLa (cervix epithelioid carcinoma). At concentrations in the range of 10 μM, GeGe-3 significantly restricted cell proliferation and metabolism. GeGe-3 also reduced PC3 cell migration in a standard wound closure and trans-well assay. Together, these results confirm the anticancer potential of GeGe-3 and underline the need for more detailed pre-clinical investigations into its molecular targets and mechanisms of action.
Citation
Williams, A., Cooper, E., Clark, B., Perry, L., Ponassi, M., Iervasi, E., …Ladomery, M. (2024). Anticancer effects of the Novel Pyrazolyl-Urea GeGe-3. International Journal of Molecular Sciences, 25(10), Article 5380. https://doi.org/10.3390/ijms25105380
Journal Article Type | Article |
---|---|
Acceptance Date | May 10, 2024 |
Online Publication Date | May 15, 2024 |
Publication Date | May 15, 2024 |
Deposit Date | May 15, 2024 |
Publicly Available Date | May 15, 2024 |
Journal | International Journal of Molecular Sciences |
Print ISSN | 1661-6596 |
Electronic ISSN | 1422-0067 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 25 |
Issue | 10 |
Article Number | 5380 |
DOI | https://doi.org/10.3390/ijms25105380 |
Keywords | pyrazole; novel anticancer drugs; cell proliferation; cell migration |
Public URL | https://uwe-repository.worktribe.com/output/11989250 |
Additional Information | The article is part of a Special Issue entitled "ynthesis and Biological Evaluation of Pyrazole Derivatives" |
Files
Anticancer effects of the Novel Pyrazolyl-Urea GeGe-3
(2 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
BCL–3 promotes cyclooxygenase–2/prostaglandin E2 signalling in colorectal cancer
(2020)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search